Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Weiss

Showing results (21-30 of 181) with videos related to

Pageof 19
Sort By:
Plos Pathogens|June 7, 2019
Heteroresistance: A cause of unexplained antibiotic treatment failure?Victor I Band, David S Weiss
The Journal of Biological Chemistry|September 13, 2002
Identification of a tyrosine in the agonist binding site of the homomeric rho1 gamma-aminobutyric acid (GABA) receptor that, when mutated, produces spontaneous openingViviana I Torres, David S Weiss
Frontiers in Cellular and Infection Microbiology|April 29, 2014
CRISPR-Cas systems: new players in gene regulation and bacterial physiologyTimothy R Sampson, David S Weiss
Plos Pathogens|October 23, 2013
Alternative roles for CRISPR/Cas systems in bacterial pathogenesisTimothy R Sampson, David S Weiss
Journal of Bacteriology|April 15, 2020
Francisella novicida CRISPR-Cas Systems Can Functionally Complement Each Other in DNA Defense while Providing Target FlexibilityHannah K Ratner, David S Weiss
Biochemical Society Transactions|November 22, 2013
Cas9-dependent endogenous gene regulation is required for bacterial virulenceTimothy R Sampson, David S Weiss
Nature Microbiology|January 6, 2025
Zinc-dependent β-lactam resistance at a costJacob E Choby, David S Weiss
RNA Biology|October 9, 2013
Degeneration of a CRISPR/Cas system and its regulatory target during the evolution of a pathogenTimothy R Sampson, David S Weiss
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|December 11, 2013
Exploiting CRISPR/Cas systems for biotechnologyTimothy R Sampson, David S Weiss
RNA Biology|March 18, 2021
crRNA complementarity shifts endogenous CRISPR-Cas systems between transcriptional repression and DNA defenseHannah K Ratner, David S Weiss
Pageof 19

Showing results (21-30 of 181) with videos related to

Sort By:
Pageof 19
Plos Pathogens|June 7, 2019
Heteroresistance: A cause of unexplained antibiotic treatment failure?Victor I Band, David S Weiss
The Journal of Biological Chemistry|September 13, 2002
Identification of a tyrosine in the agonist binding site of the homomeric rho1 gamma-aminobutyric acid (GABA) receptor that, when mutated, produces spontaneous openingViviana I Torres, David S Weiss
Frontiers in Cellular and Infection Microbiology|April 29, 2014
CRISPR-Cas systems: new players in gene regulation and bacterial physiologyTimothy R Sampson, David S Weiss
Plos Pathogens|October 23, 2013
Alternative roles for CRISPR/Cas systems in bacterial pathogenesisTimothy R Sampson, David S Weiss
Journal of Bacteriology|April 15, 2020
Francisella novicida CRISPR-Cas Systems Can Functionally Complement Each Other in DNA Defense while Providing Target FlexibilityHannah K Ratner, David S Weiss
Biochemical Society Transactions|November 22, 2013
Cas9-dependent endogenous gene regulation is required for bacterial virulenceTimothy R Sampson, David S Weiss
Nature Microbiology|January 6, 2025
Zinc-dependent β-lactam resistance at a costJacob E Choby, David S Weiss
RNA Biology|October 9, 2013
Degeneration of a CRISPR/Cas system and its regulatory target during the evolution of a pathogenTimothy R Sampson, David S Weiss
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|December 11, 2013
Exploiting CRISPR/Cas systems for biotechnologyTimothy R Sampson, David S Weiss
RNA Biology|March 18, 2021
crRNA complementarity shifts endogenous CRISPR-Cas systems between transcriptional repression and DNA defenseHannah K Ratner, David S Weiss
Pageof 19